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SummaryMaintaining a positive calcium balance is vital for bone mineralization during postnatal development. We delineate transcellular calcium absorption pathways in the jejunum and ileum, which are present only early in life and contribute to a positive calcium balance.

The greatest net positive calcium (Ca^2+^) balance occurs in infancy.[@bib1] This process is vital to mineralizing bone throughout development.[@bib2] An estimated 60% of osteoporosis risk can be attributed to a failure to reach optimal peak bone mass density by early adulthood.[@bib3] In women, the incidence of fractures due to osteoporosis is greater than breast cancer and cardiovascular disease combined and represents a major health care burden.[@bib4], [@bib5] Infancy and childhood are thus critical periods for long-term skeletal health.

Bone Ca^2+^ deposition rate is greatest in infancy and is a direct function of intestinal absorption.[@bib1], [@bib6] Unfortunately, studies to date have not fully examined how intestinal absorption is maximized in infants to meet increased demand. Intestinal Ca^2+^ absorption can occur via passive paracellular or active transcellular pathways.[@bib7] The current hypothesized model of transcellular absorption in both humans and rodents consists of apical entry into the enterocyte through the Ca^2+^-selective channel, transient receptor potential vanilloid 6 (TRPV6), intracellular binding to calbindin-D~9k~, and basolateral extrusion via the plasma membrane Ca^2+^-ATPase 1 (PMCA1) or sodium-calcium exchanger.[@bib8], [@bib9], [@bib10] Interestingly, *Trpv6* knockout (KO) or mutant mice (*Trpv6* ^*mt*^) do not display a severe Ca^2+^ wasting phenotype, strongly inferring another apical Ca^2+^ entry channel.[@bib10], [@bib11], [@bib12] Voltage-dependent L-type calcium channel, alpha 1D subunit (Ca~v~1.3) has been proposed as a complementary channel to TRPV6.[@bib13], [@bib14] Consistent with this, one group has reported that global *Cacna1d* knockout (Ca~v~1.3 KO) mice have lower weight and decreased bone mineral density at 20 weeks in males; however, others report normal growth.[@bib15], [@bib16] Regardless, the role of Ca~v~1.3 in intestinal Ca^2+^ absorption has not been directly assessed.

The molecular components of the proposed transcellular absorption pathway are expressed in the duodenum and large intestine of adult animals, whereas paracellular absorption or secretion predominates in the jejunum and ileum.[@bib17], [@bib18], [@bib19] In contrast, existing evidence suggests that alternative Ca^2+^ absorption mechanisms are present during development compared with older animals.[@bib18], [@bib20], [@bib21] However, the exact molecular details conferring increased intestinal Ca^2+^ absorption and their contribution to bone mineralization early in life have yet to be determined.

We therefore sought to delineate the molecular details of transcellular Ca^2+^ absorption from the small intestine and how they contribute to bone mineralization during early postnatal development. We report net transcellular Ca^2+^ flux before weaning across jejunum and ileum but not duodenum at 2 weeks, with the opposite pattern present at 2 months. Furthermore, we find that TRPV6 and Ca~v~1.3 are necessary for this absorption across jejunum and that Ca~v~1.3 may mediate absorption across ileum, although compensation is present in *Cacna1d* KO pups. Furthermore, *Cacna1d* KO pups exhibit delayed bone mineralization and renal compensation to increase Ca^2+^ reabsorption. Together, this work defines the molecular details in mice of how the small intestine facilitates increased demand of Ca^2+^ early in life to meet requirements of growth.

Results {#sec1}
=======

Expression of Transcellular Ca^2+^ Absorption Mediators Is Absent From the Duodenum of Young Mice {#sec1.1}
-------------------------------------------------------------------------------------------------

To assess how transcellular Ca^2+^ absorption changes with age, we first examined the expression of known mediators in the duodenum before weaning at postnatal day 1 (P1), P7, and P14 and after weaning at 1--6 months in wild-type (WT) mice. *Trpv6* was undetectable at P1 and increased 6-fold from P14 to 1 month ([Figure 1](#fig1){ref-type="fig"}*A*). *Cacna1d,* encoding the L-type Ca^2+^ channel Ca~v~1.3, was greatest at P7 and 3 months ([Figure 1](#fig1){ref-type="fig"}*B*). Expression of *S100g*, encoding calbindin-D~9k~, was very low at P1, P7, and P14 but increased with age ([Figure 1](#fig1){ref-type="fig"}*C*). *Atb2b1*, encoding the basolateral PMCA1, followed a similar pattern ([Figure 1](#fig1){ref-type="fig"}*D*). *Slc8a1*, encoding sodium-calcium exchanger 1, showed bimodal pattern with greater expression before weaning and at 6 months ([Figure 1](#fig1){ref-type="fig"}*E*). Calbindin-D~9k~ protein was detectable by immunoblot only at and after 1 month ([Figure 1](#fig1){ref-type="fig"}*F* and *G*). Together, these results suggest that the transcellular Ca^2+^ absorption pathway is poorly expressed or not present before weaning in the duodenum.Figure 1**Transcellular J**~**Ca**~^**2+**^**flux across the duodenum is not detectable at P14 but mediated by TRPV6 in 2-month-old mice.** Relative expression of (*A*) *Trpv6,* (*B*) *Cacna1d,* (*C*) *S100g,* (*D*) *Atb2b1,* and (*E*) *Slc8a1* in the duodenum across ages (n = 12/group). Expression is normalized to *Gapdh* and relative to 1 month. (*F*) Representative immunoblot from 3 replicates and (*G*) semi-quantification of calbinidin-D~9k~. Protein abundance is normalized to GAPDH and presented relative to the 1-month group (n = 6/group). Groups compared by 1-way analysis of variance with Dunnett multiple comparisons test. \**P* \< .05 compared with 1-month group. (*H*) Net J~Ca~^2+^ across ex vivo sections of mouse duodenum is not different from 0 in P14 mice (n = 6, *P* = .095) but significantly greater than 0, consistent with absorption, in 2-month-old mice (n = 7, ^‡^*P* = .013) (two-tailed, one-sample *t* test). Net J~Ca~^2+^ is significantly reduced in 2-month-old mice after addition of 100 μmol/L ruthenium red apically under (*I*) apical hyperosmolar (n = 6; two-tailed, paired *t* test; \**P* = .006) and (*J*) iso-osmolar conditions (n = 5; two-tailed, paired *t* test; \**P* = .02). (*K*) Net J~Ca~^2+^ is significantly lower in 2-month-old *Trpv6*^*mt*^ mice compared with WT littermates (n = 6/group; two-tailed, unpaired *t* test; \**P* \< .001). One hundred μmol/L apical ruthenium red significantly decreases net J~Ca~^2+^ in WT (\**P* = .002) but not *Trpv6*^*mt*^ mice (*P* = .474) (two-tailed, paired *t* test). Both paired experiments were performed under apical hyperosmolar conditions. (*L*) One hundred μmol/L ruthenium red did not decrease net J~Ca~^2+^ in P14 mice (n = 6; two-tailed, paired *t* test; *P* = .2). Data are presented as mean ± standard error of the mean. CaBP~D9k~, calbindin-D~9k~; ND, not detected; RR, ruthenium red; *Trpv6*^*mt*^, *Trpv6* mutant.

Net Ca^2+^ Absorption Occurs Across the Duodenum at 2 Months and Is Mediated by Transient Receptor Potential Vanilloid 6 {#sec1.2}
------------------------------------------------------------------------------------------------------------------------

To functionally validate the expression pattern changes observed with age, we sought to examine Ca^2+^ flux (J~Ca~^2+^) across the duodenum of mice at P14 and 2 months. Net J~Ca~^2+^ from P14 mice was not different from 0, whereas net J~Ca~^2+^ from 2-month-old mice demonstrated absorption ([Figure 1](#fig1){ref-type="fig"}*H*). Net J~Ca~^2+^ was significantly decreased in the presence of 100 μmol/L apical ruthenium red,[@bib22] implicating TRPV6 activity ([Figure 1](#fig1){ref-type="fig"}*I*). This experiment was performed with hyperosmolar apical buffer to stimulate Trpv6 activity[@bib13], [@bib23]; however, this decrease was also noted with ruthenium red under iso-osmolar conditions ([Figure 1](#fig1){ref-type="fig"}*J*). Similarly, net J~Ca~^2+^ was significantly greater in WT compared with *Trpv6* mutant (*Trpv6* ^*mt*^) littermates expressing a pore mutation (D541A) rendering the channel non-permeable to Ca^2+^.[@bib24] Furthermore, ruthenium red significantly decreased net J~Ca~^2+^ in WT but not *Trpv6* ^*mt*^ mice ([Figure 1](#fig1){ref-type="fig"}*K*). Importantly, the drug had no effect on net J~Ca~^2+^ in P14 mice ([Figure 1](#fig1){ref-type="fig"}*L*). These results demonstrate TRPV6-mediated, transcellular Ca^2+^ absorption across duodenum, which develops by 2 months of age.

Pre-Weaned Mice Express Transcellular Ca^2+^ Absorption Mediators in the Jejunum {#sec1.3}
--------------------------------------------------------------------------------

We next examined the expression of the transcellular pathway in the jejunum. To our surprise, we identified *Trpv6* expression from P1 to P14 ([Figure 2](#fig2){ref-type="fig"}*A*). Minimal expression was detected at 1 month, but not at any older age ([Figure 2](#fig2){ref-type="fig"}*A*). *Cacna1d* expression was significantly higher at P1 to P14 relative to 1 month of age ([Figure 2](#fig2){ref-type="fig"}*B*). Similarly, expression of *S100g*, *Atp2b1*, and *Slc8a1* was significantly greater from P1 to P14 ([Figure 2](#fig2){ref-type="fig"}*C--E*). Calbindin-D~9k~ protein was detected from P1 to 1 month but was nearly undetectable from 2 to 6 months ([Figure 2](#fig2){ref-type="fig"}*F*). Ca~v~1.3 has been identified apically in the jejunum of rats.[@bib14] To determine whether we could detect Ca~v~1.3 protein in the jejunum of P14 pups, we fixed tissue from mice expressing hemagglutinin (HA)-tagged *Cacna1d*.[@bib25] We observed HA immunoreactivity in the jejunum of HA-*Cacna1d* mice but not WT mice ([Figure 3](#fig3){ref-type="fig"}). Together, these results suggest the presence of a transcellular Ca^2+^ absorption pathway in the jejunum in the first 2 weeks of life in mice, with apical entry mediated by TRPV6, Ca~v~1.3, or both channels.Figure 2**Net Ca**^**2+**^**absorption across the jejunum of P14 mice is mediated by TRPV6 and Ca**~**v**~**1.3 and is not present at 2 months.** Relative expression of (*A*) *Trpv6,* (*B*) *Cacna1d,* (*C*) *S100g,* (*D*) *Atp2b1,* and (*E*) *Slc8a1* by age (n = 12/group). Expression is normalized to *Gapdh* and relative to 1 month. (*F*) Representative calbindin-D~9k~ (CaBP~D9k~) immunoblot of 12 replicates and quantification by age (n = 12/group). Groups compared by 1-way analysis of variance with Dunnett multiple comparisons test. \**P* \< .05 compared with 1-month group. (*G*) Net J~Ca~^2+^ across ex vivo sections of mouse jejunum are greater than 0, indicating absorption at P14 (n = 7; ^‡^*P* = .03) but not 2-month-old mice (n = 6; *P* = .11; two-tailed, one-sample *t* test). (*H*) Net J~Ca~^2+^ is significantly reduced across the jejunum of P14 *Trpv6*^*mt*^ mice compared with WT littermates (n = 4 WT and 5 mt; two-tailed unpaired *t* test; \**P* = .04). (*I*) Greater expression of *Cacna1c*, encoding Ca~v~1.2, at P14 (n = 6/group; two-tailed unpaired *t* test; \**P* \< .0001) normalized to *Gapdh*. (*J*) Significantly reduced net J~Ca~^2+^ across the jejunum of P14 *Cacna1d* KO mice compared with WT mice (n = 5/group; Mann-Whitney test; \**P* = .008). Data are presented as mean ± standard error of the mean. CaBP~D9k~, calbindin-D~9k~; ND, not detected; *Trpv6*^*mt*^, *Trpv6* mutant.Figure 3**Ca**~**v**~**1.3 expression in jejunum of P14 mice.** (*A* and *B*) Immunoreactivity (*red*) of HA reveals apical localization of HA-tagged Ca~v~1.3 on sections (7 μm) of jejunum from P14 mice expressing HA-tagged *Cacna1d*. (*C*) Section of jejunum from WT mice (control) shows no HA immunoreactivity. Cell nuclei were stained with bisbenzimide (Hoechst 33342) (*blue*). (*D*) Hematoxylin-eosin staining of sections of jejunum of Ca~v~1.3-HA mice. *Scale bars*: 50 μm.

TRPV6 and Ca~v~1.3 Are Required for Net Transcellular Ca^2+^ Absorption Across the Jejunum at P14 {#sec1.4}
-------------------------------------------------------------------------------------------------

Because of the expression patterns observed, we next sought to measure transcellular J~Ca~^2+^ across the jejunum. We found net apical to basolateral J~Ca~^2+^ in P14 but not 2-month-old mice ([Figure 2](#fig2){ref-type="fig"}*G*). To specifically implicate TRPV6 in this process, we repeated the studies using *Trpv6* ^*mt*^ P14 mice. We observed significantly lower net J~Ca~^2+^ across jejunum of *Trpv6* ^*mt*^ mice compared with WT littermates ([Figure 2](#fig2){ref-type="fig"}*H*). Together, these studies infer a role for TRPV6 in Ca^2+^ absorption across the jejunum of pre-weaned mice.

Next, we aimed to determine the potential role of the L-type Ca^2+^ channel Ca~v~1.3 in net Ca^2+^ absorption across jejunum of P14 mice. We first examined the expression of other, potentially confounding L-type Ca^2+^ channels, specifically *Cacna1s*, *Cacna1c*, and *Cacna1f*. *Cacna1s* and *Cacna1f* were not detected at P14 or 2 months. However, *Cacna1c*, encoding Ca~v~1.2, was detected at both ages, with 5-fold greater expression at P14 ([Figure 2](#fig2){ref-type="fig"}*I*). Importantly, Ca~v~1.2 is more sensitive than Ca~v~1.3 to nifedipine, so this drug could not be used to specifically implicate Ca~v~1.3.[@bib26] To specifically implicate Ca~v~1.3 in net J~Ca~^2+^ observed at P14, we repeated the Ca^2+^ flux studies in *Cacna1d* KO pups.[@bib16] Net J~Ca~^2+^ was abolished in *Cacna1d* KO compared with WT animals, indicating that Ca~v~1.3 is required for Ca^2+^ absorption from the jejunum of P14 mice ([Figure 2](#fig2){ref-type="fig"}*J*).

The Ileum of Younger Animals Expresses Transcellular Ca^2+^ Absorption Mediators {#sec1.5}
--------------------------------------------------------------------------------

The presence of a transcellular Ca^2+^ absorption pathway in the ileum of mice before weaning was also examined. *Trpv6* expression was not detected at any age. *Cacna1d* expression was greater from P1 to P14 compared with 1- to 6-month-old mice ([Figure 4](#fig4){ref-type="fig"}*A*). A similar pattern was observed for *S100g*, *Atp2b1,* and *Slc8a1* ([Figure 4](#fig4){ref-type="fig"}*B--D*). Calbindin-D~9k~ protein expression was detected on immunoblot ([Figure 4](#fig4){ref-type="fig"}*E*), with semi-quantification ([Figure 4](#fig4){ref-type="fig"}*F*) at P1--P14 but not at 1 month of age or older. Together, these data infer transcellular Ca^2+^ absorption occurs across the ileum before weaning but not after.Figure 4**P14 but not 2-month-old mice display net apical to basolateral calcium flux across the ileum, mediated by L-type Ca**^**2+**^**channel.** Expression of (*A*) *Cacna1d,* (*B*) *S100g,* (*C*) *Atp2b1,* and (*D*) *Slc8a1* by age (n = 12/group). Expression is normalized to *Gapdh* and relative to 1 month. (*E*) Representative immunoblot of 12 repeats and (*F*) semi-quantification of calbindin-D~9k~ (CaBP~D9k~) demonstrates expression in ileum only in younger mice. Results are normalized to GAPDH and displayed relative to P14 age (n = 12/group). Groups are compared by 1-way analysis of variance with Dunnett multiple comparisons test; \**P* \< .05. (*G*) Net J~Ca~^2+^ across ex vivo sections of mouse ileum are greater than 0 at P14 (n = 6; ^‡^*P* = .001) but not 2 months (n = 6; *P* = .359) (two-tailed, one-sample *t* tests). (*H*) Ten μmol/L apical nifedipine decreases net J~Ca~^2+^ in P14 mice compared with vehicle (n = 5 vehicle and 9 nifedipine; Mann-Whitney test; \**P* = .001). (*I*) No difference in net J~Ca~^2+^ across ileum between WT and *Cacna1d* KO mice at P14 (n = 5 WT and 6 KO; Mann-Whitney test; *P* = .54). (*J*) Ten μmol/L apical nifedipine does not decrease net J~Ca~^2+^ in *Cacna1d* KO mice at P14 mice (n = 4; Wilcoxon matched-pairs signed rank test; *P* = .25). (*K*) Transepithelial resistance (TER) across the ileum of P14 WT, *Cacna1d* KO, or *Cacna1d* KO with nifedipine (1-way analysis of variance; *P* = .5) (n = 7--10/group). Unidirectional apical to basolateral (*L*) and basolateral to apical (*M*) J~Ca~^2+^ across ileum of P14 *Cacna1d* KO mice before (control) and after apical addition of 10 μmol/L nifedipine (paired *t* test; \**P* \< .05) (n = 6). Data are presented as mean ± standard error of the mean.

Net Transcellular Ca^2+^ Absorption Occurs Across the Ileum at 2 Weeks but not 2 Months {#sec1.6}
---------------------------------------------------------------------------------------

To determine whether transcellular Ca^2+^ absorption occurs across the ileum of P14 mice, we measured Ca^2+^ flux across this segment ex vivo in Ussing chambers. In FVB/N WT mice, net J~Ca~^2+^ was significantly greater than 0 in P14 but not 2-month-old mice ([Figure 4](#fig4){ref-type="fig"}*G*). Because *Trpv6* was not detectable at any age in ileum, we sought to implicate Ca~v~1.3 in mediating the net absorption. To do so, we repeated the flux studies in P14 mice in the presence of vehicle or 10 μmol/L nifedipine and observed a significant inhibition of net J~Ca~^2+^ ([Figure 4](#fig4){ref-type="fig"}*H*). To more specifically implicate Ca~v~1.3, we repeated the experiments in WT and *Cacna1d* KO mice at P14. However, we did not observe lower net J~Ca~^2+^ in the KO mice ([Figure 4](#fig4){ref-type="fig"}*I*). To determine whether another L-type Ca^2+^ channel was compensating for the loss of *Cacna1d*, we repeated net J~Ca~^2+^ studies with 10 μmol/L nifedipine. Again, no difference was observed between groups ([Figure 4](#fig4){ref-type="fig"}*J*). This made us examine the results more closely. The transepithelial resistance was not different across the ileum of WT and *Cacna1d* KO with or without nifedipine ([Figure 4](#fig4){ref-type="fig"}*K*). Unidirectional apical to basolateral ^45^Ca^2+^ flux was slightly increased after addition of nifedipine; however, basolateral to apical ^45^Ca^2+^ flux also increased slightly after nifedipine treatment ([Figure 4](#fig4){ref-type="fig"}*L* and *M*), likely because of increased tissue permeability over time in this ex vivo experiment. Regardless, together, these results suggest net transcellular Ca^2+^ absorption across the ileum of mice at P14 is mediated by an L-type Ca^2+^ channel with compensation by a non--L-type Ca^2+^ channel after genetic deletion of Ca~v~1.3.

Delayed Bone Mineralization in Cacna1d KO Pups {#sec1.7}
----------------------------------------------

We next queried whether the loss of net transcellular Ca^2+^ absorption from the jejunum of *Cacna1d* KO and *Trpv6* ^*mt*^ pups altered bone mineralization at P14. Femur growth plate thickness measured on toluidine blue--stained sections was greater in *Cacna1d* KO ([Figure 5](#fig5){ref-type="fig"}*A--C*, [Table 1](#tbl1){ref-type="table"}) but not *Trpv6* ^*mt*^ ([Table 2](#tbl2){ref-type="table"}) compared with WT pups. These results suggest delayed bone mineralization in the *Cacna1d* KO mice. No other differences were observed in trabecular bone between WT and *Cacna1d* KO ([Table 1](#tbl1){ref-type="table"}) or WT and *Trpv6* ^*mt*^ ([Table 2](#tbl2){ref-type="table"}) pups as determined by alizarin red staining ([Figure 5](#fig5){ref-type="fig"}*D*). Similarly, no differences were observed for cortical bone parameters as assessed by micro--computed tomography (μCT) ([Figure 5](#fig5){ref-type="fig"}*E*) for either WT vs *Cacna1d* KO pups ([Table 1](#tbl1){ref-type="table"}) or WT vs *Trpv6* ^*mt*^ pups ([Table 2](#tbl2){ref-type="table"}). Together, these data suggest that Ca~v~1.3 contributes to maintaining a positive Ca^2+^ balance during postnatal growth, whereas TRPV6 is not critical at this age.Figure 5**Bone phenotype of *Cacna1d* KO pups.** Representative toluidine blue--stained sections from fixed non-decalcified femurs of (*A*) WT and (*B*) *Cacna1d* KO mice at P14 (P13-P15). The growth plate thickness was measured in middle of the section as indicated below. *Scale bar* = 1 mm (*upper panels*) and 0.2 mm (*lower panels*). (*C*) Representative toluidine blue--stained sections obtained from non-decalcified femur (*top*) and enlarged region covering the growth plate (GP) used to determine thickness of growth plate shown in [Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}. (*D*) Representative alizarin red stain used to visualize calcified bone (*red*) and to calculate trabecular parameters shown in [Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}. Region of interest (ROI) starting at growth plate (GP) and covering primary spongiosa over 750 μm is indicated. (*E*) Lateral scout view of femur indicating midshaft section used to analyze cortical bone.Table 1Trabecular and Cortical Bone Parameters of P14 WT and *Cacna1d* KO MiceMaleFemaleWT*Cacna1d* KOWT*Cacna1d* KOTrabecular bone N6556 BV/TV (*%*)20.3 ± 0.9219.2 ± 2.6820.7 ± 2.117.2 ± 1.03 Trabecular number (*1/mm*)0.012 ± 0.0010.011 ± 0.0010.013 ± 0.0010.011 ± 0.001 Trabecular width (*μm*)16.5 ± 0.3716.6 ± 0.8816.1 ± 0.3515.6 ± 0.42 Trabecular separation (*μm*)65.4 ± 3.0675.0 ± 9.864.3 ± 6.6376.4 ± 5.95 Growth plate thickness (*μm*)343.4 ± 14.6426.2 ± 30.9[a](#tbl1fna){ref-type="table-fn"}361.1 ± 25.5484.5 ± 17.2[b](#tbl1fnb){ref-type="table-fn"}Cortical bone N6749 Bone volume (*mm*^*3*^)0.056 ± 0.0030.059 ± 0.0050.061 ± 0.0040.067 ± 0.003 Endocortical volume (*mm*^*3*^)0.26 ± 0.010.25 ± 0.010.26 ± 0.010.27 ± 0.01 Cross-sectional thickness (*mm*)0.043 ± 0.0020.045 ± 0.0030.047 ± 0.0020.050 ± 0.002 Perimeter (*mm*)3.87 ± 0.093.76 ± 0.093.74 ± 0.073.87 ± 0.03 Tissue mineral density (*g/cm*^*3*^)0.98 ± 0.010.98 ± 0.010.99 ± 0.011.01 ± 0.01[^1][^2][^3][^4]Table 2Trabecular and Cortical Bone Parameters of P14 WT and *Trpv6*^*Mt*^ MiceNWT*Trpv6*^*mt*^Trabecular bone BV/TV (*%*)321.6 ± 1.2521.4 ± 1.6 Trabecular number (*1/mm*)30.013 ± 0.00090.013 ± 0.0002 Trabecular width (*μm*)317.3 ± 0.4419.0 ± 1.12 Trabecular separation (*μm*)363.3 ± 6.060.2 ± 2.1 Growth plate thickness (*μm*)3652.5 ± 18.0630.2 ± 19.6Cortical bone Femur length (*mm*)58.26 ± 0.258.07 ± 0.14 Bone volume (*mm*^*3*^)50.074 ± 0.0040.078 ± 0.004 Endocortical volume (*mm*^*3*^)50.18 ± 0.0070.19 ± 0.006 Cross-sectional thickness (*mm*)50.062 ± 0.0020.068 ± 0.004 Perimeter (*mm*)53.37 ± 0.093.42 ± 0.05 Tissue mineral density (*g/cm*^*3*^)51.04 ± 0.011.05 ± 0.01[^5][^6]

Renal and Intestinal Compensation for Loss of Ca~v~1.3 {#sec1.8}
------------------------------------------------------

To understand the lack of a severe bone phenotype in *Cacna1d* KO and *Trpv6* ^*mt*^ pups, we examined the expression of genes that might compensate for the loss of jejunal Ca^2+^ absorption in the intestine and kidney. We observed no difference in *Trpv6* or *S100g* expression along the length of the intestine in *Cacna1d* KO pups ([Figure 6](#fig6){ref-type="fig"}*A* and *C*). However, we did find a 2-fold increase in *Cacna1c*, encoding Ca~v~1.2, expression in the ileum but not in other segments ([Figure 6](#fig6){ref-type="fig"}*B*). It is unlikely that Ca~v~1.2 contributes to compensatory increased net J~Ca~^2+^ in this segment because we observed nifedipine-insensitive flux in the *Cacna1d* KO pups ([Figure 4](#fig4){ref-type="fig"}*J*). In contrast, we observed significant up-regulation of mediators of renal Ca^2+^ reabsorption in the proximal tubule and thick ascending limb (TAL), the segments responsible for a combined 90% of renal Ca^2+^ reabsorption.[@bib7] Specifically, the *Cldn2* and *Nhe3* genes that encode a calcium permeable pore and generate the driving force for Ca^2+^ reabsorption from the proximal tubule, respectively, were increased in *Cacna1d* KO pups ([Figure 6](#fig6){ref-type="fig"}*D* and *E*).[@bib27], [@bib28], [@bib29] Furthermore, we observed increased expression of *Cldn16* and *Cldn19*, genes that encode the Ca^2+^ permeable pore in the TAL ([Figure 6](#fig6){ref-type="fig"}*F* and *G*).[@bib30] No differences were observed in expression of *Cldn14,* which blocks Ca^2+^ reabsorption in the TAL,[@bib31] or *Trpv5* and *Calb1,* which mediate transcellular Ca^2+^ reabsorption in the distal nephron ([Figure 6](#fig6){ref-type="fig"}*H--J*).[@bib8] Interestingly, *Trpv6* ^*mt*^ pups had significantly decreased expression of *Cacna1d* in the jejunum, ileum, and cecum ([Figure 7](#fig7){ref-type="fig"}*A*), although no differences were observed in *S100g* expression ([Figure 7](#fig7){ref-type="fig"}*B*). Contrary to findings in *Cacna1d* KO pups, renal expression of *Cldn2*, *Nhe3*, *Cldn16*, and *Cldn19* was not different in *Trpv6* ^*mt*^ compared with WT mice ([Figure 7](#fig7){ref-type="fig"}*C--F*). We did identify a significant decrease in both *Cldn14* and *Trpv5* expression ([Figure 7](#fig7){ref-type="fig"}*G--I*). Together, these results suggest compensatory increases in renal Ca^2+^ reabsorption in *Cacna1d* KO pups.Figure 6**Renal compensation in *Cacna1d* KO mice at P14.** Quantitative real-time PCR results of (*A*) *Trpv6*, (*B*) *Cacna1c* encoding Ca~v~1.2, and (*C*) *S100g* along the intestine. Renal expression of (*D*) *Cldn2,* (*E*) *Nhe3*, (*F*) *Cldn16*, (*G*) *Cldn19*, (*H*) *Cldn14*, (*I*) *Trpv5*, and (*J*) *Calb1* encoding calbindin-D~28k~ reveals compensatory increases in *Cacna1d* KO pups. Small intestine and kidney results are normalized to *Gapdh*; cecum results are normalized to *β-actin*. All expression results are displayed relative to WT group for each tissue. \**P* \< .05 vs WT by Mann-Whitney test. (n = 6/group). Data are presented as mean ± standard error of the mean. Duod, duodenum; Jej, jejunum.Figure 7**Compensatory expression changes in *Trpv6***^***mt***^**pups.** Quantitative real-time PCR results of (*A*) *Cacna1d* and (*B*) *S100g* encoding calbindin-D~9k~ along the intestine from *Trpv6*^*mt*^ pups relative to WT expression in each tissue. Quantitative real-time PCR expression of mediators of renal Ca^2+^ reabsorption, (*C*) *Cldn2,* (*D*) *Nhe3*, (*E*) *Cldn16*, (*F*) *Cldn19*, (*G*) *Cldn14*, (*H*) *Trpv5*, and (*I*) *Calb1* encoding calbindin-D~28k~ in *Trpv6*^*mt*^ pups relative to WT. Small intestine and kidney results are normalized to *Gapdh*; cecum and proximal colon (P.Col) results are normalized to *β-actin*. All expression results are relative to WT group for each tissue. \**P* \< .05 vs WT by Mann-Whitney test. (n = 6/group). Data presented as mean ± standard error of the mean. Duod, duodenum; Jej, jejunum; mt, mutant.

Early Weaning Alters Expression of Trpv6, Cacna1d, and S100g in the Jejunum and Ileum {#sec1.9}
-------------------------------------------------------------------------------------

To determine whether weaning from breast milk to a regular chow diet results in the changes in expression observed, we weaned pups at P12, roughly 7 days before they are typically weaned, collected tissue 48 hours later, and compared gene expression to littermates that were not weaned early. We observed a 2-fold increase in expression of *Trpv6* and a 1.8-fold increase in *S100g* in the jejunum of pups weaned early. Furthermore, jejunal *Cacna1d* was decreased by 38% in pups weaned early ([Figure 8](#fig8){ref-type="fig"}*A--C*). In the ileum, *Cacna1d* expression was also decreased by 66% with early weaning, whereas no difference was observed in *S100g* ([Figure 8](#fig8){ref-type="fig"}*D* and *E*). Together, these results suggest that expression of these pathways is regulated by a bioactive compound in breast milk and/or dietary calcium changes.Figure 8**Early weaning to rodent chow alters *Trpv6*, *Cacna1d,* and *S100g* expression in jejunum and ileum at P14.** Quantitative real-time PCR results of (*A*) *Trpv6*, (*B*) *Cacna1d,* and (*C*) *S100g* in jejunum and (*D*) *Cacna1d* and (*E*) *S100g* in ileum. Tissue was taken from mice at P14 after either early weaning to rodent chow at P12 or not. Results are normalized to *β-actin*. \**P* \< .05, \*\*\**P* \< .0001 vs P14 mice not weaned by Mann-Whitney or unpaired *t* test. (n = 7--8/group). Data are presented as mean ± standard error of the mean.

Discussion {#sec2}
==========

The lifetime osteoporosis risk is independently related to bone mineral content accrued early in life.[@bib32] Infancy and adolescence represent the 2 periods of greatest Ca^2+^ accretion into bone. When normalized to body weight, the rate of calcium deposition into bone is greatest in the first year of life.[@bib1], [@bib6] A positive calcium balance is necessary for this deposition rate and is a linear function of intestinal absorption. Thus, intestinal absorptive capacity is greatest during infancy.[@bib1] We identify active Ca^2+^ absorption across distal small intestinal segments in mice from 1 day to 6 months of age. Our results failed to identify transcellular Ca^2+^ absorption in the duodenum until after weaning, whereas significant net absorption from the jejunum and ileum occurs only in early postnatal development. Furthermore, TRPV6 and Ca~v~1.3 mediate this novel absorption pathway identified in the jejunum, whereas absorption across the ileum is mediated by an L-type Ca^2+^ channel, likely Ca~v~1.3 ([Figure 9](#fig9){ref-type="fig"}).Figure 9**Summary of apical entry mechanisms contributing transcellular Ca**^**2+**^**absorption across the small intestine before and after weaning.** Significant net transcellular Ca^2+^ absorption across the duodenum is mediated by apical TRPV6 and is present only after weaning. In the jejunum, significant net transcellular Ca^2+^ absorption is present only before weaning and is mediated by apical TRPV6 and Ca~v~1.3. Similarly, significant net transcellular Ca^2+^ absorption occurs only before weaning across the ileum and is mediated by an L-type calcium channel.

Previous studies have examined expression of the transcellular Ca^2+^ absorption pathway in the duodenum at various ages.[@bib21], [@bib33] TRPV6 and calbindin-D~9k~ were first identified at 1 week in mice, which is consistent with our findings.[@bib21], [@bib34] We observed *Trpv6* at P7 and P14; however, the expression was far below that of older mice. Similarly, calbindin-D~9k~ was nearly undetectable before 1 month. Calbindin-D~9k~ expression is induced by transcellular Ca^2+^ absorption and maintains a low free cytosolic Ca^2+^ concentration.[@bib35] The dramatic shift in expression of the apical entry channel, ie, Trpv6, and intracellular buffer, ie, calbindin-D~9K~, indicates that this pathway is not present in the duodenum of mice before 1 month. Indeed, we observed absorption at 2 months but not P14. This is consistent with previous in situ ligated loop studies in rats demonstrating duodenal absorption occurs only via an unsaturable, paracellular process up to P14, with increasing prevalence of a saturable, transcellular process thereafter.[@bib18], [@bib36] We extended this observation and reveal that TRPV6 is essential to net transcellular duodenal Ca^2+^ absorption at 2 months through pharmacologic inhibition and a TRPV6 pore mutant. This is consistent with previous findings that lumen to serum ^45^Ca^2+^ flux after oral gavage of 3-month-old *Trpv6* KO mice is reduced by 40%--50% compared with WT.[@bib12] Importantly, transcellular Ca^2+^ absorption across the duodenum does not contribute to net absorption before weaning. Therefore, there must be other mechanisms mediating Ca^2+^ absorption at a young age.

Previous studies failed to identify transcellular Ca^2+^ absorption in the jejunum and ileum while noting significant paracellular secretion in 9- to 15-week-old mice.[@bib17], [@bib19] A study using in situ ligated loops in 16-day-old rats measured absorption along the length of the small intestine.[@bib37] However, this technique does not fully capture serosal to lumen recycling and thus cannot definitively demonstrate transcellular absorption. We observed transcellular absorption across the jejunum and ileum before weaning but not thereafter. In addition, our gene expression profiling supported our functional observations. Importantly, we detected calbindin-D~9k~ protein in mice up to P14. Previous work detected calbindin-D~9k~ in rat ileum at 2 months but at a level less than-one fifth of duodenum. However, other work has failed to find expression in mice at 1 month of age.[@bib18], [@bib20] These findings illustrate that active Ca^2+^ uptake from distal small bowel is an alternative pathway to meet the high requirements of infancy.

We further reveal the molecular identity of this developmental Ca^2+^ absorption pathway in the jejunum. Net transcellular J~Ca~^2+^ was absent from the jejunum of both *Trpv6* ^*mt*^ and *Cacna1d* KO mice at P14, clearly implicating both channels. Prior work using perfused jejunal loops of adult rats found decreased unidirectional lumen to serosal flux on apical addition of nifedipine and therefore suggested that Ca~v~1.3 contributes to intestinal Ca^2+^ absorption at later ages.[@bib38] However, their study has been contradicted by further work in rodents.[@bib19] Collectively, these results illustrate the potential role of Ca~v~1.3, but not in early postnatal development. Our study clearly illustrates the importance of Ca~v~1.3 in the jejunum before weaning. It is unclear whether TRPV6 and Ca~v~1.3 directly or indirectly interact to mediate Ca^2+^ absorption in this segment; however, both appear to be necessary.

The ileum is the longest intestinal segment with the longest sojourn time and thus could contribute significantly to a positive Ca^2+^ balance early in life.[@bib39] Some authors have speculated the existence of transcellular Ca^2+^ absorption across the ileum of mice and humans.[@bib13], [@bib40], [@bib41] However, before the current work, no functional measurements were performed before weaning. Morgan et al[@bib14] observed J~Ca~^2+^ that was inhibited by L-type Ca^2+^ channel blockers in the jejunum of older rats. Combined with protein detected in the jejunum and ileum, the authors suggested that Ca~v~1.3 mediates Ca^2+^ absorption. However, direct functional measurements on the ileum did not support this. Ussing chambers studies on 9- to 15-week-old mice did not find net J~Ca~^2+^.[@bib17] Further work using in situ ligated loops in 1-month-old rats found only passive diffusion without a transcellular component.[@bib18] However, we found significant net transcellular Ca^2+^ absorption across the ileum of mice at P14 that was not present at 2 months. Furthermore, this net flux was inhibited by nifedipine at a concentration that blocks both Ca~v~1.2 and Ca~v~1.3.[@bib38] To specifically implicate Ca~v~1.3, we repeated the J~Ca~^2+^ flux studies across ileum of *Cacna1d* KO pups. However, these animals did not have decreased net absorption. Interestingly, the net flux observed in the *Cacna1d* KO ileum was no longer inhibited by nifedipine, suggesting that Ca~v~1.3 mediates flux in WT animals, but that a non--L-type Ca^2+^ channel compensates when Ca~v~1.3 is knocked out. The identification of this third transcellular Ca^2+^ absorption pathway is the focus of further studies.

To determine whether the absence of net transcellular Ca^2+^ absorption across the jejunum of P14 mice negatively impacted the ability to maintain a positive Ca^2+^ balance resulting in poorly mineralized bone, we examined the bone phenotype of *Cacna1d* KO and *Trpv6* ^*mt*^ pups. We observed a significantly thicker growth plate in the *Cacna1d* KO pups relative to WT, suggesting delayed mineralization of bone in these animals. These findings are consistent with increased growth plate thickness and morphologic changes in bones of rabbits treated with nifedipine.[@bib42] Although Platzer et al[@bib16] reported normal growth, Li et al[@bib15] found decreased bone mineral content and cross-sectional area of cortical bone of male *Cacna1d* KO mice at 18 weeks of age, which is consistent with our observation. Li et al attributed the observed bone phenotype to the loss of Ca~v~1.3 in osteoblasts. Because of our findings of a key role of Ca~v~1.3 in jejunal Ca^2+^ absorption and bone mineralization at P14, it is possible that later bone mineral content differences are the result of reduced intestinal Ca^2+^ absorption early in life. It is not possible to delineate the effect of bone versus gut with the available global *Cacna1d* KO model.

In a different mutant *Trpv6* mouse strain, a 9.3% reduction in femoral bone mineral density was observed in *Trpv6* KO mice at 3 months of age on a 1% Ca^2+^ diet but not a diet without Ca^2+^.[@bib12] We did not find altered bone parameters in *Trpv6* ^*mt*^ pups, suggesting adequate intestinal Ca^2+^ absorption or renal compensation to mineralize bone. Absorption across the ileum at P14, where *Trpv6* is not expressed, likely compensates for loss of jejunal absorption.[@bib39] Interestingly, infants born with *TRPV6* mutations have skeletal abnormalities detectable in utero.[@bib43], [@bib44] This human phenotype is likely the result of decreased placental Ca^2+^ transfer, as has been observed in mice.[@bib45], [@bib46] Because bone mineralization normalizes by 2 years in these infants, humans also appear to compensate for the loss of *TRPV6* in early development. We should also acknowledge that our work and most previous molecular studies on intestinal calcium absorption have been performed on rodents, and confirmation of these molecular pathways in humans should be done.

The *Cacna1d* KO pups do not have a severe bone phenotype because of 2 compensatory mechanisms. First, transcellular Ca^2+^ absorption across the ileum of *Cacna1d* KO mice is replaced by nifedipine-insensitive flux, which is consistent with the up-regulation of a yet unidentified calcium absorption pathway. Second, *Cacna1d* KO mice also display renal compensation in the proximal tubule and TAL of the nephron to maintain Ca^2+^ balance.[@bib30], [@bib31] These results suggest that increased renal Ca^2+^ reabsorption is necessary to maintain appropriate Ca^2+^ balance, which is consistent with suboptimal Ca^2+^ absorption across the intestine in the absence of Ca~v~1.3.

To elucidate whether weaning itself caused the changes in Ca^2+^ absorption observed, we weaned mice early to a regular rodent chow diet. Unexpectedly, we observed an increase in *Trpv6* and *S100g* expression in the jejunum, but not the ileum, in the pups weaned early. *Trpv6* and *S100g* expression is up-regulated by hormones found in breast milk including epidermal growth factor and prolactin, which may stimulate expression in suckling pups.[@bib47], [@bib48] However, a change from a high to low calcium diet with early weaning may also lead to activation of vitamin D via parathyroid hormone, which, in turn, increases *Trpv6* and *S100g* expression, thus explaining the increased expression observed in the jejunum.[@bib49] There is a paucity of data regarding the free Ca^2+^ concentration available in each segment of the intestine from breast milk or chow diet, which is then available for absorption. It is likely that the postprandial lumen Ca^2+^ concentrations are in the millimolar range. *Cacna1d* expression was decreased with early weaning similar to our observations with age, suggesting its regulation by a bioactive compound in breast milk such as prolactin.[@bib50] Further studies are required to delineate the mechanisms mediating the intestinal Ca^2+^ absorption changes observed at weaning.

In conclusion, we identified pathways mediating active transcellular Ca^2+^ absorption in the jejunum and ileum early in life. TRPV6 and Ca~v~1.3 mediate this absorption in the jejunum. Pharmacologic blockade of L-type Ca^2+^ channels prevents net absorption in the ileum where TRPV6 is absent. The loss of Ca~v~1.3 induces a compensatory increase in Ca^2+^ absorption from the ileum and renal Ca^2+^ reabsorption in pre-weaned mice despite delayed bone mineralization. Furthermore, we have demonstrated that a change in diet from breast milk to solid food causes shifts in expression of these pathways in the jejunum and ileum. We have therefore identified molecular details of how active Ca^2+^ uptake from the intestine contributes to the increased demand early in life.

Methods {#sec3}
=======

Mice {#sec3.1}
----

FVB/N (Taconic Biosciences, Rensselaer, NY) and *Trpv6* ^*mt*^ mice[@bib24] were maintained on a 12-hour light/dark cycle with drinking water and chow ad libitum (Lab Diet Irradiated Rodent Diet 5053, 4% fat, 0.81% calcium). Experiments were approved by the University of Alberta animal ethics committee, Health Sciences Section (AUP00000213). Experiments on the *Cacna1d* and HA-tagged *Cacna1d* KO mice[@bib16] were conducted in agreement with the European Communities Council Directive (2010/63/EU) in accordance with the German law on the use of laboratory animals and approved by the regional board for scientific animal experiments of Saarland. *Trpv6* ^*mt*^ mice were genotyped by polymerase chain reaction (PCR).[@bib24], [@bib51] For the early weaning experiments, half of the mice in a litter (FVB/N mice) were weaned at P12 to the standard rodent chow diet, and the littermates remained with the dam. After 48 hours, tissue was collected from all pups. Experiments involving mice included both female and male mice in approximately equal numbers except for the bone phenotype analysis of P14 *Trpv6* ^*mt*^ mice.

Isolation of Tissue {#sec3.2}
-------------------

Murine tissue was taken as previously described,[@bib9] snap frozen in liquid nitrogen, and stored at --80°C until use. At each age, the length of the whole small intestine was measured. The duodenum was defined at the first ninth, the jejunum as the second two-ninths, and ileum as the remaining two-thirds of the length. For expression studies, tissue was taken from the middle of these defined sections. For experiments in Ussing chambers at P14, the duodenum was defined as the first 2 cm, jejunum from 5 to 7 cm, and ileum as 14--16 cm from the pyloric sphincter. For 2-month-old mice, the duodenum was taken as the first 4.6 cm, jejunum as 10--14.8 cm, and ileum as 22--26.8 cm.

Quantitative Real-time Polymerase Chain Reaction {#sec3.3}
------------------------------------------------

Total RNA was isolated from tissue as described.[@bib52] Briefly, RNA was isolated by using the TRIzol method (Invitrogen, Carlsbad, CA; cat.\# 15596026) and treated with DNAse (ThermoScientific, Vilnius, Lithuania; cat.\# EN0521). RNA quality and quantity were measured with a Nanodrop 2000 (Thermo Fisher Scientific, Waltham, MA). Five micrograms of RNA was then reverse transcribed into cDNA (SuperScript II; Invitrogen; cat.\# 18064014). Quantitative real-time PCR was performed in triplicate for each sample by using TaqMan Universal Master Mix II (Applied Biosystems, Foster City, CA; cat.\# 4440042) and specific primers and probes on a ABI 7900HT Sequence Detection System (Applied Biosystems) as previously shown.[@bib52] Primer and probe sequences for murine *Trpv6*, *S100g*, *Atp2b1*, *Slc8a1*, *Gapdh*, *18s*, and *β-actin* have been published elsewhere.[@bib9], [@bib52] Sequences for murine *Cacna1d* primers and probe (forward: TCCTCTTCCTCTTCACCTACTG; reverse: AGTCAACCAGATAGCCAACAG; probe: CCCTTACCCGCCCTGTGATGT) were created by using IDT software (Integrated DNA Technologies, San Diego, CA), and specificity was assessed with NCBI Primer-BLAST. Samples were quantified by using the standard curve method where the standard curve was made of serial dilutions of cDNA from a positive control or the target tissue. A C~t~ value greater than 35 was considered negligible.

Immunoblotting {#sec3.4}
--------------

Tissue was lysed in RIPA buffer (50 mmol/L Tris, 150 mmol/L NaCl, 1 mmol/L EDTA, 1% Triton-X, 1% sodium dodecyl sulfate, 1% NP-40, pH 7.4) with phenylmethylsulfonyl fluoride to 1:1000 concentration (Thermo Scientific, Rockford, IL; cat.\# 36978) and protease inhibitor set III to 1:100 concentration (Calbiochem, San Diego, CA; cat.\# 535140) for 1 hour on ice and then centrifuged for 10 minutes at 14,000 centrifugal force at 4°C. The protein content of the supernatant was quantified against a standard curve of serial dilutions of bovine serum albumin (Sigma-Aldrich, St Louis, MO; cat.\# A-9647) using a Nanodrop 2000 (Thermo Fisher Scientific, Waltham, MA).

For immunoblots, 150 μg protein from total lysate was run on a 15% sodium dodecyl sulfate--polyacrylamide gel electrophoresis, electrotransferred to 0.45 μm polyvinylidene difluoride membrane (Merck Millipore, Burlington, MA; cat.\# IVPH00010), and blocked overnight in tris-buffered saline tween with 5% milk. The blot was then incubated overnight at 4°C with either rabbit anti--calbindin-D~9k~ (1:1000; Swant, Marly, Switzerland; cat.\# CB9) or mouse anti-GAPDH (1:1000; Thermo Fisher Scientific, Rockford, IL; cat.\# MA5-15738), followed by incubation for 1 hour at room temperature with horseradish peroxidase--conjugated donkey anti-rabbit or goat anti-mouse immunoglobulin G (1:5000; Santa Cruz Biotechnology Inc, Santa Cruz, CA; cat.\# sc-2005, sc-2317) and visualized using Clarity Western ECL (Bio-Rad, Hercules, CA; cat.\# 1705061) and a ChemiDoc Touch imaging system (Bio-Rad). Protein was semi-quantified with ImageJ (U. S. National Institutes of Health, Bethesda, MD), and each sample was normalized to GAPDH as a loading control and one age group as indicated to enable the combination of results from several blots.

Micro--Computed Tomography Analysis of Femora {#sec3.5}
---------------------------------------------

Femurs from P14 *Trpv6* ^*mt*^ and *Cacna1d* KO and WT mice were scanned by μCT at a resolution of 6.5 μm (Bruker μCT SkyScan 1172; Billerica, MA). The bones were wrapped into wet paper, placed in a plastic holder, and mounted vertically in the sample chamber for scanning. Voltage and current x-rays source were adjusted to 49 kV and 200 μA, respectively, and beam hardening was reduced by using a 0.5-mm Al filter; the exposure time was 5 seconds, and scanning angular rotation was set to 180° with an increment of 0.4° rotation step.[@bib53] NRecon (1.6.10.6) was used to reconstruct, and DataViewer (1.5.1.2) and CT Analyser (1.16.4.1+; all from Bruker) were used for bone analysis. A total of 50 cross sections (6.5 μm) exactly in the middle of femoral shaft were analyzed to access the cortical bone volume, endocortical volume, cross-sectional thickness, perimeter, and mineral density.

Non-Decalcified Bone Histology {#sec3.6}
------------------------------

Femurs were fixed in 4% PFA at 4°C and incubated in 30% (w/v) sucrose solution overnight. Samples were then embedded in an anterior-posterior orientation in tissue freezing medium (simulated colonic environment medium; CEM-001; Section-Lab Co Ltd, Hiroshima, Japan) according to Kawamoto and Shimizu[@bib54] and stored at --80°C until sectioning. Four 6-μm sections per bone were made in an anterior-posterior orientation at 2 different regions spaced at least 100 μm from each other. Two sections were stained with a modified toluidine blue staining to visualize cartilage. The thickness of the growth plate was determined from the middle of the section. The mean of either 2 per bone was taken as a single value. Two sections were stained with alizarin red to visualize calcified bone (red) and to calculate trabecular parameters as previously published.[@bib55]

Immunohistochemistry {#sec3.7}
--------------------

Sections of the jejunum were prepared and fixed with Zamboni's fixative solution at 4°C for 12 hours and transferred to 30% (w/v) sucrose solution at 4°C for 12 hours. Samples were embedded in tissue freezing medium optical cutting temperature (Leica Microsystems GmbH, Wetzlar, Germany) and cut into 7-μm sagittal sections with a cryostat. Sections were incubated with primary anti-HA antibody overnight (1:1000, clone 3F10; Roche, Basel, Switzerland; cat.\# 11867431001), followed by 1-hour incubation with a secondary antibody (donkey anti rat-Cy3; Jackson Immuno Research, Cambridgeshire, United Kingdom; cat.\# 712-165-150), followed by incubation in the presence of 1 μg/mL bisbenzimide (Hoechst 33342; Sigma-Aldrich, Munich, Germany) for 5 minutes. Images were collected on an Axio Scan.Z1 microscope via the Plan-Apoichromat 20x/0.8 M27 objective, equipped with AxioVision 4.7 or Zen 2.3 software (all from Zeiss, Oberkochen, Germany).

Ussing Chamber Studies {#sec3.8}
----------------------

Net ^45^Ca flux (J~Ca~) was measured essentially as previously.[@bib17] Fresh intestinal tissue was excised from mice, linearized, mounted onto Ussing chamber sliders, and placed into the corresponding P2400/P2300 Ussing chambers connected to a VCC multichannel voltage/current clamp (Physiologic Instruments, San Diego, CA). Whole-thickness intestinal tissue was used for all experiments because our previous work found no difference between stripped tissue and full thickness for Ca^2+^ fluxes across all the intestinal segments.[@bib17] A maximum of 4 segments were mounted per tissue, and the mean of biological replicates was used for analysis. For experiments using P2407B sliders, the internal resistance offset of the voltage/current clamp was increased by the manufacturer to compensate for the artificially increased fluid resistance created by the small aperture of the sliders.

Tissue was bathed on both sides with 4 mL Kreb's Ringer buffer (140 mmol/L Na, 5.2 mmol/L K, 120 mmol/L Cl, 1.2 mmol/L Mg, 1.2 mmol/L Ca, 2.8 mmol/L PO~4~, 2.5 mmol/L HCO~3~, pH = 7.4) at 37°C and bubbled with 5% CO~2~ (balance O~2~).[@bib56] The buffer contained 2 μmol/L indomethacin (from 10 mmol/L stock solubilized in 100% EtOH) (Sigma-Aldrich; cat.\# I7378) bilaterally and 0.1 μmol/L tetrodotoxin (Alomone Labs, Jerusalem, Israel; cat.\# T-550) basolaterally to inhibit prostaglandin synthesis and neuronal activity.[@bib57] The basolateral side contained 10 mmol/L dextrose, and the apical side contained 10 mmol/L mannitol to balance osmolarity.

After 15 minutes under open circuit conditions, 2-mV pulses were applied 3 times across the tissue for 20 seconds, and the resulting current was recorded to calculate the resistance of the tissue by using Ohm's law. One side of each chamber was then spiked with ^45^Ca (5 μCi/mL) (PerkinElmer Health Sciences, Waltham, MA; cat.\# NEZ013001MC) and the potential difference clamped to 0 mV across the tissue, and time was set to 0 minutes. Thereafter, samples of 50 μL were taken in quadruplicate from both sides at 15-minute intervals for 4 time points. For experiments with ruthenium red (Sigma-Aldrich, Oakville, Canada; cat.\# R275-1), a 5 mmol/L stock was added apically to a final concentration 100 μmol/L at time 45 minutes, and after 20 minutes of incubation, samples were collected for 3 time points at 15-minute intervals. Where indicated, nifedipine (Sigma-Aldrich; cat.\# N7634) was added to a final concentration 10 μmol/L apically.[@bib14] In P14 FVB/N mice ([Figure 4](#fig4){ref-type="fig"}*H*), experiments were performed under vehicle and nifedipine conditions on separate animals. For P14 *Cacna1d* KO mice ([Figure 4](#fig4){ref-type="fig"}*J*), experiments were performed on tissue from the same mouse as above for experiments with ruthenium red. After samples were collected, the tissue was clamped at 2 mV, as described above, to calculate the post-experiment resistance. Data were excluded if the transepithelial resistance changed by more than 40%.[@bib17] To further assess tissue viability, forskolin (LC Laboratories, Woburn, MA; cat.\# F-9929) was added to a final concentration of 10 μmol/L bilaterally. The tissue was considered viable if an increase in short circuit current of greater than 50% was observed.[@bib17]

Radioactivity of samples was measured with an LS6500 Multi-Purpose Scintillation Counter (Beckman Coulter, Brea, CA) as an average count per minute over 3 minutes. J~Ca~^2+^ was calculated as the rate of appearance of ^45^Ca^2+^ in the "cold" chamber (ie, not spiked with ^45^Ca^2+^) in cpm/h divided by the specific activity of the hot chamber (ie, spiked with ^45^Ca^2+^) in cpm/mol and normalized to surface area of tissue exposed.[@bib58] Net J~Ca~^2+^ was calculated as flux from apical to basolateral side minus flux from basolateral to apical side for tissues with a difference in resistance less than 25%.[@bib17] Because the potential difference across the tissue was clamped to 0 mV throughout the experiment and there were equimolar concentrations of Ca^2+^ in both hemichambers, there was no electrochemical gradient to drive net paracellular diffusion of Ca^2+^. Therefore, net J~Ca~^2+^ represents transcellular flux, and a positive value indicates net absorption.[@bib17]

Although transcellular Ca^2+^ absorption is known to occur across the duodenum of adult rodents, previous studies have not consistently found net absorption with protocols similar to those used in the current study.[@bib8], [@bib17] It is known that TRPV6 is activated under hyperpolarizing conditions.[@bib13] Therefore, we sought to optimize experimental conditions for absorption in the duodenum by inducing a hyperpolarized state. Previously, it has been shown that apical hyperosmolar conditions induce hyperpolarization of the apical membrane of epithelial cells.[@bib23] We therefore increased the osmolarity of our apical buffer by 100 mOsm (Osmometer Model 3D3; Advanced Instruments, Inc, Pomona, CA) with the addition of 100 mmol/L mannitol. Net J~Ca~^2+^ under apical hyperosmolar conditions across duodenum of 2-month-old FVB/N mice was 42.65 ± 8.7 nmol·h^--1^·cm^--2^ compared with 26.26 ± 7.5 nmol·h^--1^·cm^--2^ (n = 7/group; *P* = .18, two-tailed Student *t* test). Net J~Ca~^2+^ across the duodenum of P14 FVB/N mice under apical hyperosmolar conditions was not different than under iso-osmolar conditions, 18.6 ± 16.0 nmol·h^--1^·cm^--2^ vs 5.86 ± 2.85 nmol·h^--1^·cm^--2^ (n = 6/group; *P* = .45, two-tailed Student *t* test), and not significantly different from 0 (*P* = .3, one sample *t* test). Data presented for the net J~Ca~^2+^ across duodenum of all mice were obtained under apical hyperosmolar conditions except where indicated.

Quantification and Statistical Analysis {#sec3.9}
---------------------------------------

Statistical analyses were carried out by using GraphPad Prism 7.03 (GraphPad Software Inc, San Diego, CA). Groups were compared by unpaired *t* test, paired *t* test, one-way analysis of variance with Dunnett multiple comparisons test, or Mann-Whitney test as indicated in figure and table legends. All n indicated in figure legends represent samples from independent mice. The Brown-Forsythe test was used to assess equality of group variance. A non-parametric test was performed when variance was significantly different between groups. *P* \<.05 was considered significant. All authors had access to the study data and had reviewed and approved the final manuscript. Figures were created using CorelDRAW 2017 and the Mind the Graph platform ([www.mindthegraph.com](http://www.mindthegraph.com){#intref0010}).
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[^1]: NOTE. Trabecular bone parameters were calculated from bone sections stained with alizarin red and cortical bone parameters as measured by μCT. Data are presented as mean ± standard error of the mean (unpaired, two-tailed *t* test KO vs WT for each sex).

[^2]: BV/TV, bone volume/tissue volume.

[^3]: *P* \< .05.

[^4]: *P* \< .01.

[^5]: NOTE. Trabecular bone parameters calculated from bone sections stained with alizarin red and cortical bone parameters as measured by μCT. Data are presented as mean ± standard error of the mean (unpaired Student *t* test).

[^6]: BV/TV, bone volume/tissue volume.
